About Home Monitoring
BIOTRONIK Home Monitoring® is a pioneering and award-winning remote cardiac monitoring system. Designed to minimize patient effort, it sends daily, automatic cardiac device data to the patient device that then forwards the information to the Home Monitoring Service Center (HMSC). Home Monitoring not only allows physicians to safely review cardiac function, it also sends alerts about relevant changes in patient health and the device’s status. Thus, Home Monitoring allows the continuous monitoring of both the patient’s condition and the device.
Home Monitoring covers patients in more than 65 countries worldwide and is available for heart patient with:
- Cardiac monitors
- Implantable defibrillators (ICDs)
- Cardiac resynchronization therapy (CRT) devices
How Home Monitoring Works
(1) Cardiac Device with Integrated RF-Antenna
Devices equipped with Home Monitoring (T-devices) have additional storage capacity and contain a small RF-antenna for wireless communication and data transmission from the implant to a wireless patient device, the CardioMessenger.
Home Monitoring has no negative effects on devices’ battery life.
(2) The CardioMessenger Patient Device
Every night, the CardioMessenger automatically collects and transmits important, encrypted health information to the BIOTRONIK service center using the global network of T-Mobile and its partners (GPRS).
(3) A Web-Based Monitoring Platform
The transmitted patient data is collected, automatically analyzed and filtered at the BIOTRONIK Home Monitoring Service Center, according to patients‘ needs as defined by their physician. Health and system-related issues are ranked and marked in order of importance. All event and trend reports can be accessed and reviewed on a protected online platform.
The Benefits of BIOTRONIK Home Monitoring
Remote patient management with Home Monitoring offers the opportunity to deliver event-driven care, rather than a one-size-fits-all approach.
Various studies demonstrate that Home Monitoring significantly improves clinical outcomes and survival compared to periodic, in-person device follow-up.
One of the largest and the most contemporary studies is IN-TIME, which showed a substantial decrease in mortality for patients with heart failure of more than 50%.
Home Monitoring also has been also shown to reduce: Hospitalizations caused by atrial arrhythmias or strokes by 66%.
Early Detection of Unpredictable and Silent Events: The inability of standard care regimes to quickly detect health issues can delay therapeutic interventions and preventable disease progression.
Safe Replacement of Office Visits
Past guidelines recommended the in-person follow-up of device patients every three to six months, which is time- and resource-intensive for patients and healthcare providers. Relying solely on in-office visits may deny valuable and potentially life-saving information from healthcare providers for 90 to 180 days.
BIOTRONIK Home Monitoring offers a convenient and safe alternative that is highly accepted by and easy to use.
With BIOTRONIK Home Monitoring, healthcare providers have a complementary option to routine follow-up visits, while maintaining in-person follow-ups every 12 months. It allows follow-up appointments to be catered to each patient, so that patients are seen when needed, rather than on a pre-set schedule.
TRUST (45% reduction of in-office visits for ICD patients) and COMPAS (56% fewer clinic visits for pacemaker patients) trial results in the study area.